Offices of Howard G. Smith announces that it is investigating
potential claims on behalf of investors of Galena Biopharma, Inc.
("Galena" or the "Company") (NASDAQ:GALE) concerning possible violations
of federal securities laws. The investigation focuses on certain
statements issued by the Company concerning Galena's operations.
Galena focuses on developing oncology treatments to address major unmet
medical needs to advance cancer care, and is developing immunotherapy
product candidats for the treatment of various cancers based on the E75
peptide. The investigation is related to an article published February
12, 2014, on the financial website TheStreet, alleging that
Galena has engaged in a misleading "brand awareness campaign designed to
boost Galena's stock price." The article claims that the Company hired a
stock-promotions firm to tout Galena stock but some of the firm's
marketing tactics "appear to resemble stock promotion schemes which run
afoul of standard investor relations practices." TheStreet
article further claims that Galena insiders have made millions of
dollars by selling Company stock in January.
If you purchased Galena shares, if you have information or would like to
learn more about these claims, or if you have any questions concerning
this announcement or your rights or interests with respect to these
matters, please contact Howard G. Smith, Esquire, of Law Offices of
Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania
19020 by telephone at (215) 638-4847, Toll Free at (888) 638-4847, or by
email to firstname.lastname@example.org,
or visit our website at www.howardsmithlaw.com.
[ Back To NFVZone's Homepage ]